A large and increasing number of patients in the world use medicinal plants and herbs for health purposes.Especially,chemoprevention using readily available natural substances from vege.tables,fruits,herbs and spices ...A large and increasing number of patients in the world use medicinal plants and herbs for health purposes.Especially,chemoprevention using readily available natural substances from vege.tables,fruits,herbs and spices is one of the significantly important approaches for cancer prevention in the present era.Saffron is native to Iran and now recorded in "Chinese Pharmacopoeia" as a widely used Chinese medicine with good safety.Other than several useful pharmacological effects such as anticonvulsant,antidepressant,anti-inflammation,saffron and its active components(crocin,crocetin and safranal) have been shown to induce apoptosis in several tumor cell lines and mouse tumors with beneficial properties including radical scavenging,anti-mutagenic and immuno-modulating effects.In addition,saffron was reported good potential to alleviate the toxicity ofcisplatin,including the nephrotox.icity.However,the application of these components in the clinic has been limited due poor clinical trials data.This review aimed to provide a brief overview on clinical evaluation for anti-tumor potential and current molecule mechanism of saffron based on recent literature data.展开更多
Since the beginning of 2017, Chinese Journal of Cancer has published a series of important questions in cancer research and clinical oncology to promote cancer research and accelerate collaborations. In this article, ...Since the beginning of 2017, Chinese Journal of Cancer has published a series of important questions in cancer research and clinical oncology to promote cancer research and accelerate collaborations. In this article, 10 questions are presented as followed. Question 76. How to develop effective therapeutics for cancer cachexia? Question 77.How can we develop preclinical animal models to recapitulate clinical situations of cancer patients for more effective anti-cancer drug development? Question 78. How can we develop novel effective therapeutics for pancreatic cancer and hepatocellular carcinoma? Question 79. What are the true beneficial mechanisms of antiangiogenic therapy in cancer patients? Question 80. How to approach the complex mechanisms of interplay among various cellular and molecular components in the tumor microenvironment? Question 81. Can tissue oxygenation improve the efficacy of conventional chemotherapy on cancer? Question 82. Can tissue oxygenation improve the efficacy of radiotherapy on digestive system tumors including liver cancer? Question 83. Can we integrate metabolic priming into multimodal management of liver cancer? Question 84. Has the limit of anti-androgen strategy in prostate cancer treatment been reached by the new generation of anti-androgen drugs? Question 85. Can we identify individuals with early-stage cancers via analyzing their clinical and non-clinical information collected from social media, shopping history, and clinical, pathological, and molecular traces?展开更多
目的评价药师干预口服抗肿瘤药物患者用药依从性的成效。方法采用计算机检索PubMed,Web of Science,Embase及中国知网、维普和万方医学数据库中药师对口服抗肿瘤药物患者用药依从性进行干预的相关研究,检索时限为自建库起至2022年4月1...目的评价药师干预口服抗肿瘤药物患者用药依从性的成效。方法采用计算机检索PubMed,Web of Science,Embase及中国知网、维普和万方医学数据库中药师对口服抗肿瘤药物患者用药依从性进行干预的相关研究,检索时限为自建库起至2022年4月1日。采用Cochrane偏倚风险评价工具RoB2进行偏倚风险评价,采用RevMan 5.4软件进行Meta分析,无法进行Meta分析的结局指标进行描述性统计。结果共纳入8项随机对照试验(RCT),涉及患者717例。常见的用药依从性干预措施为定期随访、用药教育和咨询。测量方法包括直接评估法和间接评估法,其中直接评估法通过测量血药浓度;间接评估法包括客观评估法(药片计数法和电子监测设备)和主观评估法(患者问卷调查)。4项以患者是否依从用药二分类变量为结局指标的RCT的Meta分析结果显示,药师对口服抗肿瘤药物患者进行药学干预可显著提高其用药依从性[OR=4.59,95%CI(1.09,19.29),P=0.04];亚组分析结果显示,采用主观评估法评估用药依从性的研究中,干预组的用药依从性显著提高[OR=6.84,95%CI(2.84,16.50),P<0.0001]。结论药师积极对口服抗肿瘤药物患者进行药学干预,可提高患者的用药依从性。展开更多
基金The project supported by National Natural Science Foundation of China (81503113)
文摘A large and increasing number of patients in the world use medicinal plants and herbs for health purposes.Especially,chemoprevention using readily available natural substances from vege.tables,fruits,herbs and spices is one of the significantly important approaches for cancer prevention in the present era.Saffron is native to Iran and now recorded in "Chinese Pharmacopoeia" as a widely used Chinese medicine with good safety.Other than several useful pharmacological effects such as anticonvulsant,antidepressant,anti-inflammation,saffron and its active components(crocin,crocetin and safranal) have been shown to induce apoptosis in several tumor cell lines and mouse tumors with beneficial properties including radical scavenging,anti-mutagenic and immuno-modulating effects.In addition,saffron was reported good potential to alleviate the toxicity ofcisplatin,including the nephrotox.icity.However,the application of these components in the clinic has been limited due poor clinical trials data.This review aimed to provide a brief overview on clinical evaluation for anti-tumor potential and current molecule mechanism of saffron based on recent literature data.
文摘Since the beginning of 2017, Chinese Journal of Cancer has published a series of important questions in cancer research and clinical oncology to promote cancer research and accelerate collaborations. In this article, 10 questions are presented as followed. Question 76. How to develop effective therapeutics for cancer cachexia? Question 77.How can we develop preclinical animal models to recapitulate clinical situations of cancer patients for more effective anti-cancer drug development? Question 78. How can we develop novel effective therapeutics for pancreatic cancer and hepatocellular carcinoma? Question 79. What are the true beneficial mechanisms of antiangiogenic therapy in cancer patients? Question 80. How to approach the complex mechanisms of interplay among various cellular and molecular components in the tumor microenvironment? Question 81. Can tissue oxygenation improve the efficacy of conventional chemotherapy on cancer? Question 82. Can tissue oxygenation improve the efficacy of radiotherapy on digestive system tumors including liver cancer? Question 83. Can we integrate metabolic priming into multimodal management of liver cancer? Question 84. Has the limit of anti-androgen strategy in prostate cancer treatment been reached by the new generation of anti-androgen drugs? Question 85. Can we identify individuals with early-stage cancers via analyzing their clinical and non-clinical information collected from social media, shopping history, and clinical, pathological, and molecular traces?
文摘目的评价药师干预口服抗肿瘤药物患者用药依从性的成效。方法采用计算机检索PubMed,Web of Science,Embase及中国知网、维普和万方医学数据库中药师对口服抗肿瘤药物患者用药依从性进行干预的相关研究,检索时限为自建库起至2022年4月1日。采用Cochrane偏倚风险评价工具RoB2进行偏倚风险评价,采用RevMan 5.4软件进行Meta分析,无法进行Meta分析的结局指标进行描述性统计。结果共纳入8项随机对照试验(RCT),涉及患者717例。常见的用药依从性干预措施为定期随访、用药教育和咨询。测量方法包括直接评估法和间接评估法,其中直接评估法通过测量血药浓度;间接评估法包括客观评估法(药片计数法和电子监测设备)和主观评估法(患者问卷调查)。4项以患者是否依从用药二分类变量为结局指标的RCT的Meta分析结果显示,药师对口服抗肿瘤药物患者进行药学干预可显著提高其用药依从性[OR=4.59,95%CI(1.09,19.29),P=0.04];亚组分析结果显示,采用主观评估法评估用药依从性的研究中,干预组的用药依从性显著提高[OR=6.84,95%CI(2.84,16.50),P<0.0001]。结论药师积极对口服抗肿瘤药物患者进行药学干预,可提高患者的用药依从性。
